Your browser doesn't support javascript.
loading
Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress.
Renken, Stefanie; Nakajima, Takahiro; Magalhaes, Isabelle; Mattsson, Jonas; Lundqvist, Andreas; Arnér, Elias S J; Kiessling, Rolf; Wickström, Stina Linnea.
Afiliación
  • Renken S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Nakajima T; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Magalhaes I; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Mattsson J; Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Lundqvist A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Arnér ESJ; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
  • Kiessling R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Wickström SL; Theme Cancer, Patient area Head and Neck, Lung and Skin, Karolinska University Hospital, Stockholm, Sweden.
J Immunother Cancer ; 10(6)2022 06.
Article en En | MEDLINE | ID: mdl-35738800

Texto completo: 1 Colección: 01-internacional Asunto principal: Linfocitos Infiltrantes de Tumor / Estrés Oxidativo / Factor 2 Relacionado con NF-E2 / Inmunoterapia / Melanoma Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Asunto principal: Linfocitos Infiltrantes de Tumor / Estrés Oxidativo / Factor 2 Relacionado con NF-E2 / Inmunoterapia / Melanoma Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Suecia